Ardena announced today that it received full Good Manufacturing Practice (GMP) approval of its expanded nanomedicine facility in Oss, The Netherlands. The approval enables the pharmaceutical CDMO to conduct GMP manufacturing operations for nanomedicines. It follows a €20 million investment in a state-of-the-art 45,000-square-foot facility offering GMP-compliant Grade C and Grade D cleanrooms designed specifically…